Legalon® SIL: The antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning

Current Pharmaceutical Biotechnology

Volumn 13, Issue 10, 2012, Pages 1964-1970

  Mengs, Ulrich ^a   Pohl, Ralf Torsten ^a   Mitchell, Todd ^b  

^a Madaus AG   (Germany)

^b Dominican Hospital   (United States)

Author keywords

Acute Hepatic Failure; Amanita phalloides poisoning; Amatoxin; Antidote; Legalon SIL; Silibinin

Indexed keywords

ACETYLCYSTEINE; AMANITIN; LEGALON SIL; PENICILLIN G; SILIBININ; THIOCTIC ACID; UNCLASSIFIED DRUG;

ACUTE DISEASE; AMANITA; AMANITA PHALLOIDES; AMANITA VERNA; AMANITA VIROSA; ARTICLE; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; LIVER TOXICITY; NONHUMAN;

AMANITINS; ANIMALS; ANTIDOTES; DRUG-INDUCED LIVER INJURY; HUMANS; MOLECULAR STRUCTURE; MUSHROOM POISONING; SILYMARIN; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

AMANITA; AMANITA PHALLOIDES; BASIDIOMYCOTA; SILYBUM MARIANUM;

EID: 84866647386     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112802273353     Document Type: Article

References (43)

1. Klein, A.S.; Hart, J.; Brems, J.J.; Goldstein, L.; Lewin, K.; Busuttil, R.W. Amanita poisoning: treatment and the role of liver transplantation. Am. J. Med., 1989, 86 187-193.
2. Faulstich, H.; Zilker, T.R. In: Handbook of mushroom poisoning. Diagnosis and Treatment Spoerke, D.G.; Rumack, B.H., Eds.; CRC Press, Boca Raton, Ann Arbor, London, Tokyo, 1994; pp. 233-248.
3. Köppel, C. Clinical symptomatology and management of mushroom poisoning. Toxicon., 1993, 12 1513-1540.
4. Blackman, J. R. Clinical approach to toxic mushroom ingestion. J. Am. Board Fam. Pract., 1994, 7 31-37.
5. Bresinsky, A.; Besl, H. Giftpilze. Stuttgart, Wiss. Verlagsgesellschaft, 1985, pp. 18-35.
6. Ellenhorn, M, J.; Barceloux, D.G. In: Medical Toxicology, Diagnosis and Treatment of Human Poisoning. Elsevier, New York, 1988; 1324-1351.
7. Meunier, B.; Messner, M.; Bardaxoglou, E.; Spiliopoulos, G.; Terblanche, J. and Launois, B. Liver transplantation for severe Lepiota helveola poisoning. Liver 1994; 14 158-160.
8. Enjalbert, F.; Cassanas, G.; Rapior, S.; Renault, C. and Chaumont, J.-P. Amatoxins in wood-rotting Galerina marginata. Mycologia 2004, 96 (4), 720-729.
9. Faulstich, H. New aspects of Amanita poisoning. Klin. Wochenschr. 1979, 57 1143-1152.
10. Estes, J.E.; Selden, L.A.; Gershman, L.C. Mechanism of action of phalloidin on the polymerization of muscle actin. Biochemistry 1981, 20 708-712.
11. Beer, J.H. Der falsche Pilz. Schweiz. Med. Wschenschr., 1993, 123 892-905.
12. Bodenmüller, H.; Faulstich, H.; Wieland, T. In: Amanita Toxins and Poisoning Faulstich, H.; Kommerell, B. Wieland, T., Eds.; Verlag Witzstrock, Baden-Baden, Köln, New York, 1980; pp. 18-20.
13. Faulstich, H.; Talas, A.; Wellnoner, H.H. Toxicokinetics of labelled amatoxins in the dog. Arch. Toxicol., 1985, 56 190-194.
14. Jaeger, A.; Jehl, F.; Flesch, F.; Sauder, P.; Kopferschmitt, J. Kinetics of amatoxins in human poisoning: Therapeutic implications. Clin. Toxicol, 1993, 31 63-80.
15. Kröncke, K.D.; Fricker, G.; Meiers, P.J.; Gerok, W.; Wieland, T.; Kurz, G. Alpha-amanitin uptake into hepatocytes. J. Biol. Chem., 1986, 261 1252-1256.
16. Wieland, T.; Faulstich, H. Fifty years of amanitin. Experientia 1991, 47 1186-1193.
17. Fiume, L.; Maritozzi; V.; Nardi, F. The effect of amanitin poisoning on mouse kidney. Br. J. Exp. Pathol., 1969, 50 270-276.
18. Zilker, T.R. In: Klinische Toxikologie für die Notfall-und Intensivmedizin Zilker, T.R. ED.; Uni-Med Verlag AG, Bremen-London-Boston, 2008; pp. 257-265.
19. Letschert, K.; Faulstich, H.; Keller, D.; Keppler, D. Molecular Characterization and Inhibition of Amanitin Uptake into Human Hepatocytes. Toxicological. Sciences, 2006, 91 (1), 140-149.
20. Magdalan, J.; Piesniewska, M.; Gliniak, H. The Inhibition of alpha-Amanitin Uptake in Perfused Rat Liver. Adv. Clin. Exp. Med., 2007, 16 (3), 353-360.
21. Al-Anati, L.; Essid, E.; Reinehr, R.; Petzinger E. Silibinin protects OTA-mediated TNF-alpha release from perfused rat livers and isolated rat Kupffer cells. Mol. Nutr. Food Res., 2009, 53 460-466.
22. Sonnenbichler, J.; Zetl, I. In: Progress in Clinical and Biological Research; Cody, V; Middleton, E.; Harborne, J.B. EDs., Alan R. Liss, Inc., New York, 1986, Vol. 213 pp. 319-331.
23. Floersheim, G.L.; Eberhard, M.; Tschumi, P.; Duckert, F. Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides. Toxicol. Appl. Pharmacol., 1978, 46 455-462.
24. Vogel, G., Tuchweber, B., Trost, W.; Mengs, U. Protection by silibinin against Amanita phalloides intoxication in beagles. Toxicol. Appl. Pharmacol., 1984, 73 355-362.
25. Saller, R; Melzer, J; Reichling, J.; Meier, R. An updated systematic review of the pharmacology of silymarin. Forsch. Komplementärmed., 2007, 14 70-80.
26. Trappoliere, M.; Caligiuri, A.; Schmid, M.; Bertolani, C.; Failli, P.; Vizzutti, F.; Novo, E.; di Manzano, C.; Marra. F.; Loguercio, C.; Pinzani, M. Silybin, a component of sylimarin, exerts antiinflammatory and anti-fibrogenic effects on human hepatic stellate cells. J. Hepatol., 2009, 50 1102-1111.
27. Faulstich, H.; Jahn, W.; Wieland, T. Silybin inhibition of amatoxin uptake in the perfused rat liver. Arzneim. Forsch./Drug Res., 1980, 30 (3), 452-454.
28. Enjalbert, F.; Rapior, S.; Nouguier-Soulé, J.; Guillon, S.; Amouroux, N.; Cabot, C. Treatment of Amatoxin Poisoning: 20-Year Retrospective Analysis. Journal of Toxicology CLINICAL TOXICOLOGY., 2002, 40 (6), 715-757.
29. Floersheim G. L.; Weber O.; Tschumi P.; Ulbrich M. Die klinische Knollenblätterpilzvergiftung (Amanita phalloides): prognostische Faktoren und therapeutische Massnahmen. Schweiz. med. Wschr., 1982, 112 1164-1177.
30. Hruby K.; Csomos G.; Fuhrmann M.; Thaler H. Chemotherapy of Amanita phalloides poisoning with intravenous silibinin. Human Toxicol., 1983, 2 183-195.
31. Ganzert, M.; Felgenhauer, N.; Schuster, T.; Eyer, T.; Gourdin, C.; Zilker, T. Knollenblätterpilzvergiftung. Silibinin und Kombination von Silibinin und Penicillin im Vergleich. Dtsch. Med. Wochenschr., 2008, 133 2261-2267.
32. Mitchell, S.T.; Olson, K.R. Intravenous silibinin in the management of amatoxin poisoning: First usage in an American cohort. Clin. Toxicol. 2008, 46 (5), 396.
33. Marugg, D.; Reutter, F.W. Die Amanita phalloides-Intoxikation-Moderne therapeutische Maßnahmen und klinischer Verlauf. Schweiz Rundschau Med., 1985, 37 972-982.
34. Smetana, R.; Hruby, K.; Benesch, B.; Bauer, K.; Jahn, O. Laborchemische Diagnose und Therapiekontrolle der Amanitinintoxikation unter Silibininbehandlung. Intensivbehandlung 1986, 11 170-175.
35. Schenke, M.; Wiedemann, G.; Otte, M. Therapie der Knollenblätterpilzvergiftung. Internist Prax. 1987, 27 293-296.
36. Hruby, K. Knollenblätterpilzvergiftung. Intensivmed. 1987, 24 269-274.
37. Kelbel, C.; Weilemann, L.S. Knollenblätterpilz-Intoxikationen: Übersicht und Falldiskussion. Intensivmed. 1989, 26 354-359.
38. Nagy, I.; Pogatsa-Murray, G.; Zalanyi, S.; Komlosi, P.; Laszlo, F.; Ung, I. Amanita poisoning during the second trimester of pregnancy: a case report and a review of the literature. Clin. Investig. 1994, 72 794-798.
39. Kleist-Retzow, L.C.; Vierzig, A.; Fuchshuber, A.; Roth, B.; Michalk, D.V. Klinik und Therapie der Knollenblätterpilzvergiftung im Kindesalter. Monatsschr. Kinderheilkd. 1995, 143 1118-1127.
40. Molling, J.; Pohle, W.; Klein, H.; Welte, T. Stellenwert therapeutischer Maßnahmen bei Vergiftung mit dem grünen Knollenblätterpilz. Intensivmed., 1995, 32 37-42.
41. Carducci, R.; Armellino, M.F.; Volpe, C.; Basile, G.; Caso, N.; Apicella, A.; Basile, V. Silibinina e intossicazione acuta da Amanita phalloides. Minerva Anestesiol., 1996, 62 187-193.
42. Alves, A.; Ferreira, M.G.; Paulo, J.; França, A.; Carvalho, Á. Mushroom poisoning with Amanita phalloides-a report of four cases. Europ. J. Int. Med.,2001, 12 64-66.
43. Boyer, J.C.; Hernandez, F.; Estorc, J.; Coussaye de la, J.E.; Bali, J.P. Management of maternal Amanita phalloides poisoning during the first trimester of pregnancy: a case report and review of the literature. Clin. Chem., 2001, 47 971-974.